Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 22023154)

1.

Carbosilane dendrimer 2G-NN16 represses Tc17 differentiation in primary T CD8+ lymphocytes.

Gras R, García MI, Gómez R, de la Mata FJ, Muñoz-Fernández MA, López-Fernández LA.

Mol Pharm. 2012 Jan 1;9(1):102-10. doi: 10.1021/mp200305u. Epub 2011 Nov 16.

PMID:
22023154
2.

The inhibition of Th17 immune response in vitro and in vivo by the carbosilane dendrimer 2G-NN16.

Gras R, Relloso M, García MI, de la Mata FJ, Gómez R, López-Fernández LA, Muñoz-Fernández MA.

Biomaterials. 2012 May;33(15):4002-9. doi: 10.1016/j.biomaterials.2012.02.018. Epub 2012 Feb 27.

PMID:
22377325
3.

Changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16.

Gras R, Almonacid L, Ortega P, Serramia MJ, Gomez R, de la Mata FJ, Lopez-Fernandez LA, Muñoz-Fernandez MA.

Pharm Res. 2009 Mar;26(3):577-86. doi: 10.1007/s11095-008-9776-z. Epub 2008 Nov 25. Erratum in: Pharm Res. 2011 Mar;28(3):683-7.

PMID:
19034630
4.

Carbosilane dendrimers as gene delivery agents for the treatment of HIV infection.

Perisé-Barrios AJ, Jiménez JL, Domínguez-Soto A, de la Mata FJ, Corbí AL, Gomez R, Muñoz-Fernandez MÁ.

J Control Release. 2014 Jun 28;184:51-7. doi: 10.1016/j.jconrel.2014.03.048. Epub 2014 Apr 8.

PMID:
24721235
5.

A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.

Huber M, Heink S, Grothe H, Guralnik A, Reinhard K, Elflein K, Hünig T, Mittrücker HW, Brüstle A, Kamradt T, Lohoff M.

Eur J Immunol. 2009 Jul;39(7):1716-25. doi: 10.1002/eji.200939412.

PMID:
19544308
6.

IL-17/IFN-γ double producing CD8+ T (Tc17/IFN-γ) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12.

Tajima M, Wakita D, Satoh T, Kitamura H, Nishimura T.

Int Immunol. 2011 Dec;23(12):751-9. doi: 10.1093/intimm/dxr086. Epub 2011 Oct 29.

7.

Erratum: changes in gene expression pattern of human primary macrophages induced by carbosilane dendrimer 2G-NN16.

Gras R, Almonacid L, Ortega P, Serramia MJ, Gomez R, de la Mata FJ, Lopez-Fernandez LA, Muñoz-Fernandez MA.

Pharm Res. 2011 Mar;28(3):683-7. doi: 10.1007/s11095-010-0328-y. No abstract available.

PMID:
21116693
8.

Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes.

Weber N, Ortega P, Clemente MI, Shcharbin D, Bryszewska M, de la Mata FJ, Gómez R, Muñoz-Fernández MA.

J Control Release. 2008 Nov 24;132(1):55-64. doi: 10.1016/j.jconrel.2008.07.035. Epub 2008 Aug 5.

PMID:
18727943
9.

Carbosilane dendrimers NN8 and NN16 form a stable complex with siGAG1.

Shcharbin D, Pedziwiatr E, Nowacka O, Kumar M, Zaborski M, Ortega P, de la Mata FJ, Gómez R, Muñoz-Fernandez MA, Bryszewska M.

Colloids Surf B Biointerfaces. 2011 Apr 1;83(2):388-91. doi: 10.1016/j.colsurfb.2010.11.009. Epub 2010 Nov 16.

PMID:
21145713
10.

Phenotype and functional analysis of human monocytes-derived dendritic cells loaded with a carbosilane dendrimer.

Pion M, Serramia MJ, Diaz L, Bryszewska M, Gallart T, García F, Gómez R, de la Mata FJ, Muñoz-Fernandez MÁ.

Biomaterials. 2010 Nov;31(33):8749-58. doi: 10.1016/j.biomaterials.2010.07.093. Epub 2010 Sep 15.

PMID:
20832111
11.

Gene therapy in HIV-infected cells to decrease viral impact by using an alternative delivery method.

Gonzalo T, Clemente MI, Chonco L, Weber ND, Díaz L, Serramía MJ, Gras R, Ortega P, de la Mata FJ, Gómez R, Lopez-Fernández LA, Muñoz-Fernández MA, Jiménez JL.

ChemMedChem. 2010 Jun 7;5(6):921-9. doi: 10.1002/cmdc.201000029.

PMID:
20414916
12.

Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17.

Kondo T, Takata H, Matsuki F, Takiguchi M.

J Immunol. 2009 Feb 15;182(4):1794-8. doi: 10.4049/jimmunol.0801347.

13.
14.

Gene array and protein expression profiles suggest post-transcriptional regulation during CD8+ T cell differentiation.

Cham CM, Xu H, O'Keefe JP, Rivas FV, Zagouras P, Gajewski TF.

J Biol Chem. 2003 May 9;278(19):17044-52. Epub 2003 Feb 11.

15.

Sensitive gene expression profiling of human T cell subsets reveals parallel post-thymic differentiation for CD4+ and CD8+ lineages.

Appay V, Bosio A, Lokan S, Wiencek Y, Biervert C, Küsters D, Devevre E, Speiser D, Romero P, Rufer N, Leyvraz S.

J Immunol. 2007 Dec 1;179(11):7406-14.

16.

Gene microarrays reveal extensive differential gene expression in both CD4(+) and CD8(+) type 1 and type 2 T cells.

Chtanova T, Kemp RA, Sutherland AP, Ronchese F, Mackay CR.

J Immunol. 2001 Sep 15;167(6):3057-63.

17.

Enhanced expression of lymphotactin by CD8+ T cells is selectively induced by enhancer agonist peptides of tumor-associated antigens.

Palena C, Arlen P, Zeytin H, Greiner JW, Schlom J, Tsang KY.

Cytokine. 2003 Nov 21;24(4):128-42.

PMID:
14572791
18.

Synergistic activity profile of carbosilane dendrimer G2-STE16 in combination with other dendrimers and antiretrovirals as topical anti-HIV-1 microbicide.

Sepúlveda-Crespo D, Lorente R, Leal M, Gómez R, De la Mata FJ, Jiménez JL, Muñoz-Fernández MÁ.

Nanomedicine. 2014 Apr;10(3):609-18. doi: 10.1016/j.nano.2013.10.002. Epub 2013 Oct 14.

PMID:
24135563
19.

Functional heterogeneity of human effector CD8+ T cells.

Takata H, Naruto T, Takiguchi M.

Blood. 2012 Feb 9;119(6):1390-8. doi: 10.1182/blood-2011-03-343251. Epub 2011 Dec 14.

20.

Modulation of cord blood CD8+ T-cell effector differentiation by TGF-beta1 and 4-1BB costimulation.

Kim YJ, Stringfield TM, Chen Y, Broxmeyer HE.

Blood. 2005 Jan 1;105(1):274-81. Epub 2004 Sep 7.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk